Nivolumab dye imaging in high grade glioma surgery
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests if a special dye attached to the immunotherapy drug nivolumab can help surgeons see tumor cells during surgery for high grade glioma. You may join if you are scheduled for surgery and your organs are working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a suspected high grade glioma that needs surgery
- You are scheduled for surgery to remove the tumor
- Your blood counts, liver, and kidney function are within certain ranges
- You do not have an active autoimmune disease or a history of one, with some exceptions like controlled thyroid or skin conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special dye (panitumumab-IRDye800) that helps surgeons see brain lesions more clearly during surgery. The dye attaches to a protein on cancer cells and lights up under a special camera, which may help remove more tumor safely.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
This trial is testing a new immunotherapy (nivolumab) for children, teens, and young adults with a specific type of aggressive brain tumor (glioblastoma that has a DNA repair problem). It aims to see if giving this treatment early, right after surgery, can help the immune system fight the tumor.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This trial tests a new treatment that combines a specially designed virus to attack tumor cells with an immunotherapy drug to help the immune system fight the cancer. It is for people whose high-grade glioma (a type of brain tumor) has come back after standard treatment.
This trial tests if a special dye attached to the drug nivolumab can help surgeons see cancer cells more clearly during surgery. If you have head and neck cancer and are scheduled for surgery, this study might be an option for you.
Hear when a new Brain Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.